✦ LIBER ✦

Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: Results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee

✍ Scribed by Tiseo, Paul J.; Kivitz, Alan J.; Ervin, John E.; Ren, Haobo; Mellis, Scott J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eggshell membrane in the treatment of pa

✍ Kevin J. Ruff; Anne Winkler; Robert W. Jackson; Dale P. DeVore; Barry W. Ritz 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 149 KB

Results from a single center, double-bli

✍ Kalunian, K.C.; Arendt-Nielsen, L.; Turkel, C.C.; DeGryse, R.; McAlindon, T.E.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 177 KB

A single center, double-blind, randomize

✍ Arendt-Nielsen, L.; Jiang, G.-L.; DeGryse, R.; Turkel, C.C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Tanezumab, an Anti-Nerve Growth Factor (

✍ N. Katz; D. Borenstein; C. Birbara; C. Bramson; M. Nemeth; M. Smith; M. Brown 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

PMS4 EUROQOL-5 DIMENSION HEALTH STATUS Q

✍ Kavanagh, S; Ashworth, J; Lange, B; Etropolski, MS; Van Hove, I; Rauschkolb, C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Alvimopan, a peripherally acting mu-opio

✍ Lynn Webster; Jan Peter Jansen; John Peppin; Ben Lasko; Gordon Irving; Bart Morl 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 723 KB